P536 Modern Opportunities for Vaccination PCV13 in Children Suffering Chronical Inflammation Nasopharyngeal Diseases Using Recombinant Α2b-Interferon

doi 10.1136/archdischild-2019-epa.870

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health

Related search

Adenoid Nasopharyngeal Ratio in Children Suffering From Otitis Media With Effusion

Journal of Surgery and Trauma
2018English

Use of Recombinant Α-2b-Interferon in the Treatment of Acute Respiratory Viral Diseases in Children

CHILD`S HEALTH
2016English

Vaccination of Children With Rheumatic Diseases

Epidemiology and Vaccine Prevention
2016English

Oxysterols: Cellular Effects and Relations With Chronical Diseases

Journal of Literature Pharmacy Sciences
2019English

Recombinant Interferon-Α2b Added to Oral Cyclophosphamide Either as Induction or Maintenance in Treatment-Naive Follicular Lymphoma: Final Analysis of CALGB 8691

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2009English

Response to PCV13 Vaccination in Patients With Multiple Myeloma Versus Healthy Controls

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation

Trends in Pharmacological Sciences
ToxicologyPharmacology
2015English

PUVA AND INTERFERON Α2b COMBINED THERAPY FOR PATIENTS WITH MYCOSIS FUNGOIDES: A SEVEN-YEAR RETROSPECTIVE STUDY IN RUSSIA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Switch in a Childhood Pneumococcal Vaccination Programme From PCV13 to PCV10: A Defendable Approach?

The Lancet Infectious Diseases
Infectious Diseases
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy